Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04987203
Title Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors AVEO Pharmaceuticals, Inc.
Indications

renal cell carcinoma

Therapies

Nivolumab + Tivozanib

Tivozanib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.